We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

January 20, 2022

5 Digital Health Predictions for 2022

Commentary
HealthXL Team & HealthXL Community
&

HealthXLs predictions for 2022 are coming late in January so you can separate the signal from the noise. For our 2022 predictions we’ve collected inputs from the wider digital health community to give you the full picture from diverse experts. 


We predict Pharma will continue to focus on Companion DTx

The HealthXL community predicts in the next 18-24 months pharmaceutical companies are more likely to focus on companion DTx than standalone. We expect pharma will continue the trend of retrofitting digital products to their drugs as a way to differentiate them and create more valuable products. To see an increase in pharma adoption of standalone DTx, we anticipate reimbursement for these solutions will need to be comparable to existing therapies (Eg, Aetna’s policy documents indicate the payer wasn't convinced by the results of studies conducted by some DTx products). Until then, we aren’t likely to see large pharma budgets for standalone solutions. 


We predict higher quality digital endpoints will arise from the crowd

DiMe reported their crowdsource library of digital endpoints grew from 34 unique endpoints and 12 sponsors in 2019 to 225 unique endpoints and 69 sponsors by September 2021. With several hundred unique digital endpoints already on the market, there are expectations the space will only continue to grow. However, a crowded and confusing space makes it challenging to determine the best measures. We predict that amongst this crowded market, those that are being validated and utilised as primary endpoints in drug trials will gain significant attention.


We predict there will be initiatives to increase clinician digital health education

While some HCPs are eager to adopt digital health, we’ve seen challenges in this last mile delivery. For example, even though Germany has 28 approved DiGA solutions, prescriptions have not yet taken off. To drive adoption we will see new CME curriculum focused on digital health education. Programs such as Weill Cornell Medicine’s Center for Virtual Care, the  Boehringer Ingelheim DH academy, and the The Topol Programme for Digital Fellowships in Healthcare in the UK, have recently been established for practicing medical professionals. For future medical professionals, we predict digital health education will become more embedded into traditional medical school programs. Our HealthXL community believes med students could be nurtured early via university medical programs that include education around DTx and telemedicine. This could be a future solution to the adoption challenges seen today. 

We predict fewer IPOs - more M&A and hopefully more realistic valuations 

For some companies, big late stage funding rounds translated to massive valuations in 2021. In 2022 we predict there will be fewer IPOs as valuations for public and private digital health companies recalibrate to more realistic numbers. However, there may be an increase in consolidation by private equity firms of digital health companies as well as strategic M&A. Much of the M&A may come from larger corporations who can still afford high valuations and where business model pressures from changing market dynamics are acute. 


We predict digital health approvals and activations won’t be as high as people expect
We anticipate long trial times will lead to delays and drop outs in digital health reimbursement pathways. We’ve also seen countries face challenges in determining the appropriate approval criteria and regulatory bodies to vet solutions. These systematic setup delays may also decrease the number of approvals and activations seen in the next year. 

We’re looking forward to seeing all that’s to come in digital health throughout this next year! Join our HealthXL community to stay up to date on the latest trends and developments in the space. 


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Adoption of Prescription DTx: Best Practices & Challenges

24th May @ 3:00PM AWST / 8:00AM GMT

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Join your peers in this meeting to discuss how to approach the problem and how some have already solved it. 

Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement Success in Fully-insured Health Plans vs. Self-insured

31st May @ 10:45AM EDT

Are you a DTx or Pharma company seeking to successfully navigate both fully-insured and self-insured health plan segments to get your DTx products reimbursed in the US? Join this interactive masterclass led by biopharma and DTx reimbursement expert Mike Pace to learn more about this topic and share your experience with the group.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Pharma - DTx: What Does Success Look Like?

2nd June @ 10:45AM EDT

In theory, Digital Therapeutics (DTx) and pharma are natural bedfellows, with both looking for commercially viable ways to connect with patients and improve outcomes. Join HealthXL in this meeting to dive deeper into this topic.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to Navigate DiGA in Germany? A Real Experience from a Digital Health Company

8th June @ 10:30AM EDT

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join this interactive masterclass led by Dr Victor Stephani to dive deeper into this topic and discuss the matter further with your peers in this field.

Featuring
Dr. Victor Stephani
Dr. Victor Stephani
Chief of Staff, HelloBetter
Featuring
Dr. Victor Stephani
Dr. Victor Stephani
Chief of Staff, HelloBetter

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Adoption of Prescription DTx: Best Practices & Challenges

24th May @ 3:00PM AWST / 8:00AM GMT

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Join your peers in this meeting to discuss how to approach the problem and how some have already solved it. 

Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Evidence Generation Strategy for Digital Health in Neurology

24th May @ 10:45AM EDT

Most neurological conditions are complex diseases with no disease-modifying therapies. Join HealthXL in this meeting to discuss this further.

Featuring
Richelle Flanagan
Richelle Flanagan
Founder at My Moves Matter
Paul Wicks
Paul Wicks
Independent Consultant, Wicks Digital Health
Featuring
Richelle Flanagan
Richelle Flanagan
Founder at My Moves Matter
Paul Wicks
Paul Wicks
Independent Consultant, Wicks Digital Health
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology

Sprint: Virtual Care in Oncology: HCP and Patient Adoption (Part 1)

25th May @ 10:45 AM EDT

Are you struggling with getting HCPs and patients to adopt your digital health solution in oncology? Apply now to join this series of two meetings to discuss this topic further and learn from your peers.

Featuring
Carole Tremonti
Carole Tremonti
VP Clinical Strategy, Project Ronin
Maike Schmitz
Maike Schmitz
Oncology Lead, RoX Health
Featuring
Carole Tremonti
Carole Tremonti
VP Clinical Strategy, Project Ronin
Maike Schmitz
Maike Schmitz
Oncology Lead, RoX Health
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Masterclass: Clinical Evidence for Digital Health: Standards and Expectations

31st May @10:45 AM EDT

Digital health vendors often seek payer collaborations, and solid clinical evidence is often needed to support this pathway. Join this interactive masterclass led by Jordan Silberman (Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.) to engage with your others in this field and discuss this matter further.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.